Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept
- PMID: 16713481
- DOI: 10.1016/j.jaad.2005.08.032
Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept
Abstract
This article reports on the combined use of alefacept and etanercept in 3 patients whose psoriasis failed to respond adequately to etanercept. All patients maintained improvement for at least 8 weeks after completing 12 weeks of alefacept. No adverse events or infections were reported, and CD4+ T-cell counts remained above normal limits.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
